Lexington, MA – King Street Properties, an owner/developer/operator of life sciences properties in Massachusetts, announced a major expansion at its Hayden Avenue campus in Lexington.
Dicerna Pharmaceuticals Inc. currently occupies more than 90,000sf at 75 Hayden Avenue and will now add an additional 107,283sf in the nearby 65 Hayden Avenue building. The company entered into its first lease with King Street for 37,000sf in 2014. With this lease expansion, the company will occupy more than 275,000sf in Lexington – nearly 200,000 of that with King Street Properties.
“We are thrilled to continue our long relationship as they expand their presence in Lexington,” said Chris Rouches, managing director at King Street. “Life sciences continue to thrive throughout the Greater Boston area and the King Street team is proud to provide first-rate facilities to support companies conducting innovative work.”
The Hayden Research Campus, which is jointly owned by King Street Properties and Healthpeak Properties, is located adjacent to Routes 2 and 95 in Lexington. The site houses several life sciences firms including Dicerna, Frequency Therapeutics, Concert Pharmaceuticals, Valo Health, Voyager Therapeutics, and Takeda Pharmaceuticals.
